223 related articles for article (PubMed ID: 27880985)
1. Daily pain in adults with sickle cell disease-a different perspective.
van Tuijn CF; Sins JW; Fijnvandraat K; Biemond BJ
Am J Hematol; 2017 Feb; 92(2):179-186. PubMed ID: 27880985
[TBL] [Abstract][Full Text] [Related]
2. Daily home opioid use in adults with sickle cell disease: The PiSCES project.
Smith WR; McClish DK; Dahman BA; Levenson JL; Aisiku IP; de A Citero V; Bovbjerg VE; Roberts JD; Penberthy LT; Roseff SD
J Opioid Manag; 2015; 11(3):243-53. PubMed ID: 25985809
[TBL] [Abstract][Full Text] [Related]
3. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project.
McClish DK; Levenson JL; Penberthy LT; Roseff SD; Bovbjerg VE; Roberts JD; Aisiku IP; Smith WR
J Womens Health (Larchmt); 2006 Mar; 15(2):146-54. PubMed ID: 16536678
[TBL] [Abstract][Full Text] [Related]
5. The role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell disease.
Tawfic QA; Faris AS; Kausalya R
J Pain Symptom Manage; 2014 Feb; 47(2):334-40. PubMed ID: 23856095
[TBL] [Abstract][Full Text] [Related]
6. Home management of pain in sickle cell disease: a daily diary study in children and adolescents.
Dampier C; Ely E; Brodecki D; O'Neal P
J Pediatr Hematol Oncol; 2002 Nov; 24(8):643-7. PubMed ID: 12439036
[TBL] [Abstract][Full Text] [Related]
7. Pain management in children with sickle cell disease.
Stinson J; Naser B
Paediatr Drugs; 2003; 5(4):229-41. PubMed ID: 12662119
[TBL] [Abstract][Full Text] [Related]
8. Characterization of opioid use in sickle cell disease.
Han J; Zhou J; Saraf SL; Gordeuk VR; Calip GS
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):479-486. PubMed ID: 28815799
[TBL] [Abstract][Full Text] [Related]
9. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
[No Abstract] [Full Text] [Related]
10. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
[TBL] [Abstract][Full Text] [Related]
11. Sickle cell disease patients' perceptions of emergency department pain management.
Porter J; Feinglass J; Artz N; Hafner J; Tanabe P
J Natl Med Assoc; 2012; 104(9-10):449-54. PubMed ID: 23342819
[TBL] [Abstract][Full Text] [Related]
12. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
Puri L; Nottage KA; Hankins JS; Anghelescu DL
Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
[TBL] [Abstract][Full Text] [Related]
13. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.
Nobrega R; Sheehy KA; Lippold C; Rice AL; Finkel JC; Quezado ZMN
Pediatr Res; 2018 Feb; 83(2):445-454. PubMed ID: 28902183
[TBL] [Abstract][Full Text] [Related]
14. Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study.
Sinha CB; Bakshi N; Ross D; Krishnamurti L
JAMA Netw Open; 2019 May; 2(5):e194410. PubMed ID: 31125105
[TBL] [Abstract][Full Text] [Related]
15. Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study.
Gerardin M; Rousselet M; Couec ML; Masseau A; Guerlais M; Authier N; Deheul S; Roussin A; Micallef J; Djezzar S; ; Feuillet F; Jolliet P; Victorri-Vigneau C
PLoS One; 2021; 16(3):e0248649. PubMed ID: 33735176
[TBL] [Abstract][Full Text] [Related]
16. Frequently asked questions by hospitalists managing pain in adults with sickle cell disease.
Smith WR; Jordan LB; Hassell KL
J Hosp Med; 2011 May; 6(5):297-303. PubMed ID: 21661104
[TBL] [Abstract][Full Text] [Related]
17. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
Yale SH; Nagib N; Guthrie T
Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
[TBL] [Abstract][Full Text] [Related]
18. Daily assessment of pain in adults with sickle cell disease.
Smith WR; Penberthy LT; Bovbjerg VE; McClish DK; Roberts JD; Dahman B; Aisiku IP; Levenson JL; Roseff SD
Ann Intern Med; 2008 Jan; 148(2):94-101. PubMed ID: 18195334
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
[TBL] [Abstract][Full Text] [Related]
20. Quality of life assessments in a cohort of Mozambican children with sickle cell disease.
Issa F; Dang BN; Buck WC; Chicumbe S; Nicolau N; Virate C; Cassamo N; Dias A; Amodo F
Pan Afr Med J; 2020; 36():343. PubMed ID: 33224409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
